跳至主要内容
临床试验/NCT05556031
NCT05556031尚未招募不适用

The Reduction of Decompensation and Unnecessary Cardiac Failure Emergency Admissions: Ambulatory Heart Failure Service Model

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年10月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Clinical outcome

研究概览

简要总结

The aim of the study is to assess the efficacy of this new ambulatory service model in reducing heart failure hospitalization (HHF), improving clinical as well as functional outcomes of post-discharge patients with Heart Failure of reduced ejection fraction (HFrEF) and Heart failure with preserved Ejection Fraction (HFpEF).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dyspnoea (exertional or at rest) and 2 of the following signs:
  • Congestion on chest X-ray
  • Rales on chest auscultation
  • Clinically relevant oedema (e.g. ≥1+ on a 0 to 3+ scale)
  • Elevated jugular venous pressure
  • NT-proBNP ≥300 pg/mL (Patients with AF: NT-proBNP ≥900 pg/mL)
  • Heart failure hospitalization that requires the treatment of a minimum single dose of 40 mg of i.v. furosemide (or equivalent i.v loop diuretics)
  • Ambulatory patients

排除标准

  • Cardiogenic shock required inotropics
  • Cardiac mechanical support implantation like LVAD
  • Life expectancy less than 1 year due to underlying significant comorbidities like metastatic cancer or end-stage COPD
  • Haemodynamically severe uncorrected primary cardiac valvular disease planned for surgery or intervention during the course of the study.
  • End stage renal failure or eGFR <15 mL/min/1.73m2 as measured during index hospitalization or requiring dialysis

结局指标

主要结局

Clinical outcome

时间窗: 90 days

A composite of all-cause mortality, number of heart failure events (including hospitalization for heart failure (HHF), urgent heart failure visits and unplanned outpatient visits), time to first heart failure event will be aggregated to evaluate overall clinical outcome

次要结局

  • Kansas City Cardiomyopathy Questionnaire Total Symptom Score (KCCQ-TSS)(1 year)
  • NT-proBNP level(1 year)
  • Risk of Heart failure(1 year)
  • Quality adjusted Life years gained(1 year)
  • Change in overall Cardiac function(90 days)
  • Major Adverse Cardiovascular Event(1 year)
  • Hypertensive heart failure (HHF)(90 days after initial hospital discharge)
  • Change in 6 minute hall walk (6MHW)(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Bryan Ping Yen YAN

Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验